Literature DB >> 961424

Carcinoid tumours. Frequency in a defined population during a 12-year period.

T Berge, F Linell.   

Abstract

The frequency of carcinoids was studied in a 12-year-period (1958-1969) in Malmö, a town with a population of 220,000 at the beginning of the period and 250,000 at the end of it. Of all persons who had died in Malmö, 46 per cent were necropsied in the first year of the study and 70 per cent in the last (altogether 62.6 per cent). The series was examined in a uniform way at one department of pathology. Carcinoid tumours were found in 1.22 per cent (199 patients) of patients comprised in the entire necropsy series (16,294 autopsies). Bronchial carcinoid accounted for 0.1 percent, the remaining lesions were found in the digestive tract. About 90 per cent of the carcinoids were found incidentally at necropsy. During the same period, 44 carcinoids were diagnosed in surgical specimens examined in Malmö. The average annual frequency of carcinoid in the entire series was about 8.4 per 100,000 inhabitants, which is about 7 times as high as that recorded in the National Cancer Register applying to the whole of Sweden. The value of such country-wide reports is discussed. The carcinoid syndrome is extremely rare and was observed only once during the entire 12-year-period. The localization, frequency of metastases and sex-distribution of carcinoids are described and discussed in detail.

Entities:  

Mesh:

Year:  1976        PMID: 961424

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Scand A        ISSN: 0365-4184


  69 in total

1.  Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours.

Authors:  J K Ramage; A H G Davies; J Ardill; N Bax; M Caplin; A Grossman; R Hawkins; A M McNicol; N Reed; R Sutton; R Thakker; S Aylwin; D Breen; K Britton; K Buchanan; P Corrie; A Gillams; V Lewington; D McCance; K Meeran; A Watkinson
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

Review 2.  Endoscopic techniques to detect small-bowel neuroendocrine tumors: A literature review.

Authors:  Roberta Elisa Rossi; Dario Conte; Luca Elli; Federica Branchi; Sara Massironi
Journal:  United European Gastroenterol J       Date:  2016-07-08       Impact factor: 4.623

3.  Four tumours including neuroendocrine tumour of the ileum.

Authors:  Karen Waldon; Jonathan Raihan Abbas; Savana Shakir; Samir Afify
Journal:  BMJ Case Rep       Date:  2015-05-02

Review 4.  The clinical and laboratory correlates of an increased urinary 5-hydroxyindoleacetic acid.

Authors:  W P Tormey; R J FitzGerald
Journal:  Postgrad Med J       Date:  1995-09       Impact factor: 2.401

Review 5.  Advances in the treatment of neuroendocrine tumors.

Authors:  Matthew Kulke
Journal:  Curr Treat Options Oncol       Date:  2005-09

6.  Carcinoid and neuroendocrine tumors of the colon and rectum.

Authors:  T Philip Chung; Steven R Hunt
Journal:  Clin Colon Rectal Surg       Date:  2006-05

7.  Gastroenteropancreatic neuroendocrine tumors: 10-year experience in a single center.

Authors:  Ozcan Yildiz; Mustafa Ozguroglu; Teoman Yanmaz; Hande Turna; Suheyla Serdengecti; Gulen Dogusoy
Journal:  Med Oncol       Date:  2009-11-03       Impact factor: 3.064

8.  Is Multifocality an Indicator of Aggressive Behavior in Small Bowel Neuroendocrine Tumors?

Authors:  Allen B Choi; Jessica E Maxwell; Kendall J Keck; Andrew J Bellizzi; Joseph S Dillon; Thomas M OʼDorisio; James R Howe
Journal:  Pancreas       Date:  2017-10       Impact factor: 3.327

9.  Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan.

Authors:  Tetsuhide Ito; Hironobu Sasano; Masao Tanaka; R Yoshiyuki Osamura; Iwao Sasaki; Wataru Kimura; Koji Takano; Takao Obara; Miyuki Ishibashi; Kazuwa Nakao; Ryuichiro Doi; Akira Shimatsu; Toshirou Nishida; Izumi Komoto; Yukio Hirata; Kazuhiko Nakamura; Hisato Igarashi; Robert T Jensen; Bertram Wiedenmann; Masayuki Imamura
Journal:  J Gastroenterol       Date:  2010-02       Impact factor: 7.527

10.  Monoclonal antibodies raised against mid-gut carcinoid tumor cells.

Authors:  C Juhlin; V Papanicolaou; K Backlin; L Klareskog; E Wilander; G Akerström; K Oberg; J Rastad
Journal:  World J Surg       Date:  1990 May-Jun       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.